or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    MRUS F Merus N.V. 2.58
    INBX F Inhibrx, Inc. 1.00
    RENB F Renovaro Biosciences Inc. -0.16
    CLDX F Celldex Therapeutics, Inc. 2.88
    KRON D Kronos Bio, Inc. 3.97
    CRBU D Caribou Biosciences, Inc. 1.52
    PYXS D Pyxis Oncology, Inc. -9.52
    THAR D Tharimmune, Inc. 0.77
    MEIP D MEI Pharma, Inc. -0.45
    ARWR D Arrowhead Research Corporation 1.26
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Medicine Biopharmaceutical Clinical Medicine Drugs Multiple Myeloma Myelodysplastic Syndrome Acute Myeloid Leukemia Biotechnology Cancer Immunotherapy Cancer Treatment Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Product Immunotherapy Inflammation Janus Kinase Inhibitor Lymphocytic Leukemia Non Small Cell Lung Cancer Organic Compounds

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    IDNA D iShares Genomics Immunology and Healthcare ETF 12.11
    CANC D Tema Oncology ETF 9.79
    FBT D First Trust Amex Biotech Index Fund 7.71
    BBH D Market Vectors Biotech ETF 7.22
    MNTL D Tema Neuroscience and Mental Health ETF 4.65
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CANC to FBT Compare FBT to MNTL Compare IDNA to BBH

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 22 ARWR Arrowhead Pharmaceuticals Inc. (ARWR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
        Nov 21 PYXS Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 PYXS Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade
        Nov 20 PYXS Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
        Nov 20 PYXS Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
        Nov 20 CRBU Caribou Biosciences to Participate in Upcoming Investor Conferences
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 18 THAR Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
        Nov 18 ARWR Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
        Nov 18 ARWR Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
        Nov 17 INBX The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
        Nov 17 KRON Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
        Nov 17 MEIP Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
        Nov 16 KRON Kronos Bio Third Quarter 2024 Earnings: Beats Expectations
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biopharmaceutical Medicine Oncology Cancer Treatment Clinical Medicine Immunotherapy Adoptive Cell Transfer Advanced Solid Tumors Antineoplastic Drugs Breast Cancer Cancer Cell Cancer Therapeutics Carcinoma Clinical Development Immune System Leukemia Lymphoma Multiple Myeloma Non Small Cell Lung Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags